申请人:Mihovilovic Marko
公开号:US20140234965A1
公开(公告)日:2014-08-21
A method of inducing differentiation of mammalian cells into cardiomyocyte-like cells by contacting the mammalian cell with a triazine compound of formula (I), wherein X is independently —NR
4
— or —O—, R
4
is hydrogen or C
1-6
-alkyl; R
1
is hydroxy, C
1-6
-alkyl, C
1-6
-alkoxy, carboxy, C
1-6
-alkoxycarbonyl, halo, cyano, nitro, formyl, amino, C
1-6
-alkylamino, or di-C
1-6
-alkylamino, the C
1-6
-alkyl or -alkoxy residue being optionally substituted with one or more R
5
substituents selected from hydroxy, halo, cyano, and nitro; n is 0 to 5; R
2
is hydrogen, aryl, heteroaryl, or C
1-6
-alkyl, the aryl or heteroaryl residue being optionally substituted with one or more R
1
substituents, and where the C
1-6
-alkyl is optionally further substituted with one or more R
5
substituents; and R
3
is selected from hydrogen, halo, NR
4
R
7
, OR
7
, SR
7
, and R
7
, where the same options apply for R
7
as for R
2
; with the proviso that the compound of formula (I) is not 3-[(4,6-diphenoxy-1,3,5-triazin-2-yl)amino]benzoic acid.
一种将哺乳动物细胞诱导分化为类心肌细胞的方法,通过将哺乳动物细胞与式(I)的三嗪化合物接触,其中X独立地是—NR4—或—O—,R4是氢或C1-6-烷基;R1是羟基、C1-6-烷基、C1-6-烷氧基、羧基、C1-6-烷氧羰基、卤素、氰基、硝基、甲酰基、氨基、C1-6-烷基氨基或二C1-6-烷基氨基,其中C1-6-烷基或烷氧基残基可以选用一个或多个R5取代基,所述R5取代基被选择为羟基、卤素、氰基和硝基中的一个或多个;n为0至5;R2是氢、芳基、杂环芳基或C1-6-烷基,其中芳基或杂环芳基残基可以选用一个或多个R1取代基,而C1-6-烷基可以选用一个或多个R5取代基;R3被选择为氢、卤素、NR4R7、OR7、SR7和R7,其中对于R2和R7同样适用相同的选项;但式(I)的化合物不包括3-[(4,6-二苯氧基-1,3,5-三嗪-2-基)氨基]苯甲酸。